Skip to main content
. Author manuscript; available in PMC: 2022 Feb 14.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Oct 9;26(2):407–412. doi: 10.1016/j.bbmt.2019.10.002

Table 1.

Participant characteristics

Characteristic Lymphoma
(N=268)
Myeloma
(N=121)
P-value*
Current Age Median years (Range) 63.4 (22.2-88.7) 68.9 (33.7-84.0) <.001
Sex Female 109 (41%) 59 (49%) 0.136
Male 159 (59%) 62 (51%)
Racial/ethnic minority (n=371) Yes 18 (7%) 19 (16%) 0.005
Graft source Bone marrow 32 (12%) 0 (0%) <.001
Peripheral blood 236 (88%) 121 (100%)
High dose total body irradiation Yes 80 (36%) 2 (2%) <.001
Smoke or chew tobacco Yes 21 (8%) 12 (11%) 0.469
Body mass index (n=369) Underweight (<18.5) 5 (2%) 4 (3%) 0.237
Normal (18.5-24.9) 99 (39%) 39 (34%)
Overweight (25-30) 101 (40%) 41 (35%)
Obese (>30) 49 (19%) 32 (28%)
Relapse after transplant Yes 28 (10%) 16 (13%) 0.424
Years since transplant Median (Range) 12.0 (5.9-30.0) 8.0 (5.0-24.9) <.001
Physical component score <40 70 (27%) 45 (39%) 0.017
Mental component score <40 40 (15%) 13 (11%) 0.302
Karnofsky performance status ≥80 228 (87%) 97 (82%) 0.188
Overall health Excellent 43 (16%) 7 (6%) 0.058
Very good 95 (36%) 42 (35%)
Good 84 (32%) 49 (41%)
Fair 39 (15%) 20 (17%)
Poor 5 (2%) 2 (2%)
Work status Working/school full or part time 117 (44%) 33 (27%) 0.006
Retired 119 (44%) 73 (60%)
Other 32 (12%) 15 (12%)
Response rate 268/456 (59%) 121/209 (58%) 0.831
*

P-values are obtained from Chi-square test for categorical variables, Wilcoxon rank sum test/Kruskal Wallis test for comparing medians of continuous variables, and Anova for comparing means of continuous variables